- Forums
- ASX - By Stock
- CU6
- Ann: First patient dosed in Phase III prostate cancer trial
Ann: First patient dosed in Phase III prostate cancer trial, page-11
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.90 |
Change
-0.090(1.29%) |
Mkt cap ! $2.194B |
Open | High | Low | Value | Volume |
$7.10 | $7.21 | $6.88 | $5.982M | 856.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5436 | $6.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.92 | 675 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 7.610 |
1 | 3113 | 7.530 |
5 | 11548 | 7.270 |
3 | 4193 | 7.260 |
1 | 1049 | 7.190 |
Price($) | Vol. | No. |
---|---|---|
6.570 | 716 | 2 |
6.580 | 1898 | 3 |
6.650 | 8924 | 10 |
6.700 | 1755 | 3 |
6.720 | 434 | 3 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online